Free Trial

Charles Schwab Investment Management Inc. Sells 232,871 Shares of Constellium SE (NYSE:CSTM)

Constellium logo with Industrials background
Remove Ads

Charles Schwab Investment Management Inc. trimmed its position in shares of Constellium SE (NYSE:CSTM - Free Report) by 20.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 924,144 shares of the industrial products company's stock after selling 232,871 shares during the period. Charles Schwab Investment Management Inc. owned about 0.63% of Constellium worth $9,491,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Geneos Wealth Management Inc. bought a new stake in Constellium in the fourth quarter valued at $31,000. Quarry LP lifted its position in shares of Constellium by 45.3% in the 3rd quarter. Quarry LP now owns 7,296 shares of the industrial products company's stock worth $119,000 after purchasing an additional 2,273 shares during the period. Handelsbanken Fonder AB boosted its stake in shares of Constellium by 9.7% during the 4th quarter. Handelsbanken Fonder AB now owns 17,000 shares of the industrial products company's stock valued at $175,000 after purchasing an additional 1,500 shares in the last quarter. Point72 DIFC Ltd boosted its stake in shares of Constellium by 167.5% during the 3rd quarter. Point72 DIFC Ltd now owns 12,105 shares of the industrial products company's stock valued at $197,000 after purchasing an additional 7,580 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Constellium during the third quarter valued at about $221,000. 92.59% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Deutsche Bank Aktiengesellschaft raised Constellium from a "hold" rating to a "buy" rating and set a $15.00 price objective on the stock in a research report on Tuesday, February 25th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, Constellium presently has an average rating of "Moderate Buy" and a consensus target price of $20.25.

Remove Ads

Read Our Latest Research Report on CSTM

Constellium Stock Down 3.0 %

Shares of NYSE:CSTM traded down $0.34 during midday trading on Wednesday, reaching $10.94. The company's stock had a trading volume of 1,217,265 shares, compared to its average volume of 1,255,557. Constellium SE has a 12-month low of $9.04 and a 12-month high of $23.20. The firm has a 50 day moving average of $10.64 and a 200-day moving average of $12.03. The firm has a market capitalization of $1.57 billion, a P/E ratio of 34.17 and a beta of 1.64. The company has a quick ratio of 0.52, a current ratio of 1.28 and a debt-to-equity ratio of 1.93.

Constellium (NYSE:CSTM - Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The industrial products company reported ($0.34) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by ($0.47). The company had revenue of $1.72 billion during the quarter, compared to analysts' expectations of $1.69 billion. Constellium had a return on equity of 4.83% and a net margin of 0.67%. On average, research analysts anticipate that Constellium SE will post 1.1 earnings per share for the current year.

Constellium Profile

(Free Report)

Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the packaging, aerospace, automotive, defense, and other transportation and industry end-markets. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.

See Also

Institutional Ownership by Quarter for Constellium (NYSE:CSTM)

Should You Invest $1,000 in Constellium Right Now?

Before you consider Constellium, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Constellium wasn't on the list.

While Constellium currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads